MedPath

Treatment protocol for adult acute lymphocytic leukemia -ALL/ MRD2008

Phase 2
Conditions
adult acute lymphocytic leukemia
Registration Number
JPRN-UMIN000001519
Lead Sponsor
Fukuoka Blood & Marrow Transplant Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. B-ALL(L3) of the blast cell cell surface immune globulin positive 2. A case having double cancers 3. A case with an infectious disease having difficulty with control 4. A case with a severe mental disorder 5. The pregnancy or breast-feeding woman 6. the case that the medical attendant judged to be inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3 years disease-free survival
Secondary Outcome Measures
NameTimeMethod
5 years disease free survival, CR rate, treatment-related toxicities
© Copyright 2025. All Rights Reserved by MedPath